Investor profile
Connecticut Innovations
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Connecticut Innovations (CI) is Connecticut's strategic venture capital arm and the leading source of financing and ongoing support for innovative, growing companies in the state. CI actively seeks proof-of-concept, pre-seed, seed, and early-stage investments with a focus on biosciences, technology, and climate verticals, typically investing between $100,000 and $1.5 million per round, with larger commitments available through dedicated funds. By offering equity and debt investments, strategic guidance, and introductions to valuable partners, CI enables promising businesses to thrive across all stages of growth. CI deploys capital through several thematic funds: the $50M AI/Q Fund targeting scalable commercial AI, quantum computing, and deep tech ventures; the $100M ClimateTech Fund supporting early-stage and growth climate companies; the $200M Connecticut Bioscience Innovation Fund; and the $50M Future Fund focused on diverse ideas and industries. CI leads approximately 70% of first investments in Connecticut startups, supporting nascent companies as they build proof of concept, and partners with entrepreneurs, venture capital firms, universities, corporate innovation arms, and government organizations to grow Connecticut's innovation ecosystem.
Notable quotes
“Connecticut Innovations is one of the most active early-stage investors in the United States, and it has a reputation for having an experienced team that thoroughly analyzes its deals and provides strategic guidance.”
“CI began the new fiscal year with steady deal activity and strong participation across key sectors like healthcare, climate tech and AI.”
“Healthcare continues to be one of CI's largest areas of investment.”
Team
Matthew McCooe
Chief Executive Officer
Peter Longo
Senior Managing Director, Investments
Matthew Storeygard
Senior Managing Director, Investments & Bio Team Director
Kevin Crowley
Senior Managing Director, Investments
Alison Malloy
Managing Director, Investments
Gwen Cheni
Director, AI/Q Fund
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| CloudSEK | Series B2 | $10m | 2026-01 |
| Coinbax | Seed | $4m | 2025-12 |
| Inbox Health | Series B | $20m | 2025-09 |
| Bloom Credit | Growth | $11m | 2025-04 |
| PHYND | Seed | $10m | 2025-02 |
| Alexion Pharmaceuticals | Early Stage | — | — |
| Biohaven Pharmaceutical | Early Stage | — | — |
| VeraDermics | IPO Exit | $256m | 2026-02 |
| Budderfly | Growth | — | — |
| Driver Technologies | Early Stage | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Advantage Capital | 10 |
| LaunchCapital | 7 |
| Commerce Ventures | 5 |
| Ironwood Capital | 4 |
| Elm Street Ventures | 3 |
| Allegis Capital | 2 |
Fit check
Is Connecticut Innovations a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit